Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

On/off dropped head syndrome: A severe adverse event after prolonged treatment with MEK inhibitor.

European journal of cancer (Oxford, England : 1990) - 1 Mar 2018

Longvert C, Maisonobe T, Saiag P, Auré K

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzimidazoles
Share to Chemotherapy, Adjuvant
Share to GTP Phosphohydrolases
Share to MAP Kinase Kinase Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Neuromuscular Diseases

Share to Skin Neoplasms

Share to Syndrome

Source

Identifiers

PMID: 29254632
DOI: 10.1016/j.ejca.2017.11.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

On/off dropped head syndrome: A severe adverse event after prolonged treatment with MEK inhibitor.PMID 29254632Read ↗

The clinical development of MEK inhibitorsSemantic proximity Read ↗

Overview of Adverse Events Associated With Anti-CD19 Chimeric Antigen Receptor T-Cell TherapySemantic proximity Read ↗

Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements.Semantic proximity Read ↗

Case report: acute tumour lysis syndrome following encorafenib and binimetinib for v600E metastatic melanoma with large intra-abdominal mass.Semantic proximity Read ↗

NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?Semantic proximity Read ↗

Unusual Adverse Events in a Patient With BRAF-Mutated Non-Small Cell Lung Cancer Treated With BRAF/MEK Inhibition.Semantic proximity Read ↗

Levetiracetam-Induced Visual Impairment in a Pediatric Patient with CNS embryonal tumor: A Case ReportSemantic proximity Read ↗

Evaluation of Toxicity and Effect on Growth and Sexual Development in Children with MAPK Pathway Driven Tumors Treated with BRAF and MEK Inhibitors -- A Single Center ExperienceSemantic proximity Read ↗

Delineating Drug Class and Target-Specific Adverse Events of Kinase InhibitorsSemantic proximity Read ↗

Safety and pharmacokinetic profile of pretomanid (PA-824) in healthy Chinese participants: Results of a phase I single dose escalation studySemantic proximity Read ↗

Vemurafenib Use in an Infant for High-Risk Langerhans Cell Histiocytosis.Semantic proximity Read ↗

Relatively mild symptoms after chronic overdose with a double-dose encorafenib: a case report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.